Vasopressors and inotropic agents are widely used in critical care. However, strong evidence supporting their use in critically ill patients is lacking in many clinical scenarios. Thus, the Italian Society of Anesthesia and Intensive Care (SIAARTI) promoted a project aimed to provide indications for good clinical practice on the use of vasopressors and inotropes, and on the management of critically ill patients with shock. A panel of 16 experts in the field of intensive care medicine and hemodynamics has been established. Systematic review of the available literature was performed based on PICO questions. Basing on available evidence, the panel prepared a summary of evidence and then wrote the clinical questions. A modified semi-quantitative RAND/UCLA appropriateness method has been used to determine the appropriateness of specific clinical scenarios. The panel identified 29 clinical questions for the use of vasopressors and inotropes in patients with septic shock and cardiogenic shock. High level of agreement exists among the panel members about appropriateness of inotropes/vasopressors' use in patients with septic shock and cardiogenic shock.

Good clinical practice for the use of vasopressor and inotropic drugs in critically ill patients: State-of-the-art and expert consensus / Carsetti, A.; Bignami, E.; Cortegiani, A.; Donadello, K.; Donati, A.; Foti, G.; Grasselli, G.; Romagnoli, S.; Antonelli, M.; De Blasio, E.; Forfori, F.; Guarracino, F.; Scolletta, S.; Pepe, L. T.; Scudeller, L.; Cecconi, M.; Girardis, M.. - In: MINERVA ANESTESIOLOGICA. - ISSN 0375-9393. - 87:6(2021), pp. 714-732. [10.23736/S0375-9393.20.14866-1]

Good clinical practice for the use of vasopressor and inotropic drugs in critically ill patients: State-of-the-art and expert consensus

Grasselli G.;Romagnoli S.;Antonelli M.;Girardis M.
2021

Abstract

Vasopressors and inotropic agents are widely used in critical care. However, strong evidence supporting their use in critically ill patients is lacking in many clinical scenarios. Thus, the Italian Society of Anesthesia and Intensive Care (SIAARTI) promoted a project aimed to provide indications for good clinical practice on the use of vasopressors and inotropes, and on the management of critically ill patients with shock. A panel of 16 experts in the field of intensive care medicine and hemodynamics has been established. Systematic review of the available literature was performed based on PICO questions. Basing on available evidence, the panel prepared a summary of evidence and then wrote the clinical questions. A modified semi-quantitative RAND/UCLA appropriateness method has been used to determine the appropriateness of specific clinical scenarios. The panel identified 29 clinical questions for the use of vasopressors and inotropes in patients with septic shock and cardiogenic shock. High level of agreement exists among the panel members about appropriateness of inotropes/vasopressors' use in patients with septic shock and cardiogenic shock.
2021
87
6
714
732
Good clinical practice for the use of vasopressor and inotropic drugs in critically ill patients: State-of-the-art and expert consensus / Carsetti, A.; Bignami, E.; Cortegiani, A.; Donadello, K.; Donati, A.; Foti, G.; Grasselli, G.; Romagnoli, S.; Antonelli, M.; De Blasio, E.; Forfori, F.; Guarracino, F.; Scolletta, S.; Pepe, L. T.; Scudeller, L.; Cecconi, M.; Girardis, M.. - In: MINERVA ANESTESIOLOGICA. - ISSN 0375-9393. - 87:6(2021), pp. 714-732. [10.23736/S0375-9393.20.14866-1]
Carsetti, A.; Bignami, E.; Cortegiani, A.; Donadello, K.; Donati, A.; Foti, G.; Grasselli, G.; Romagnoli, S.; Antonelli, M.; De Blasio, E.; Forfori, F.; Guarracino, F.; Scolletta, S.; Pepe, L. T.; Scudeller, L.; Cecconi, M.; Girardis, M.
File in questo prodotto:
File Dimensione Formato  
R02Y2021N06A0714.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 1.33 MB
Formato Adobe PDF
1.33 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1280862
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 2
social impact